NBNiels Roderick Blees

Niels Roderick Blees

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Niels Roderick Blees has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Placebo-controlled randomized clinical study using a collagen hydrolysate-enriched diet in dogs with osteoarthritis

    by Niels R. Blees, Michelle Teunissen, Ineke H. Smit, Femke Verseijden, Björn P. Meij, Esther Prevo-Keijbets, Carine van Vuure, Ronald Jan Corbee, Marianna A. Tryfonidou

  • Open Access

    Surgical treatment of feline meningioma: a single-institution survival analysis

    by Kathelijn J van Heusden, Lucinda L van Stee, Niels R Blees, Wilhelmina Bergmann, Carles Planas Padrós, Björn P Meij

    Case series summary: The aim of this study was to evaluate median survival time (MST), disease-free interval (DFI) and postoperative complications of surgical resection of feline intracranial meningiomas, providing evidence for prognostic counselling for general practitioners. A retrospective review of medical records (2012–2025) identified 17 cats undergoing craniotomy or craniectomy for histologically confirmed meningiomas. Data included patient characteristics, clinical signs, imaging findings, surgical approach, complications, histopathology, recurrence and survival. MRI or CT was used for diagnosis and postoperative monitoring when available. Survival analysis employed Kaplan–Meier and competing risk models; DFI was based on clinical signs or follow-up imaging. A total of 17 cats (median age 11.6 years; 82.4% domestic shorthairs) underwent surgery. The rostrotentorial approach was most common (65%), with minor intraoperative complications in three cases. Postoperative mortality within 4 weeks was 17.6% (3/17). In total, 14 cats survived to discharge. Median follow-up was 622 days. Estimated MST was 1674 days (95% confidence interval [CI] 1395–NE [not estimable]), with 1-, 2-, 3- and 4-year survival rates of 82%, 82%, 82% and 72%, respectively. Median DFI was 377 days (855 days for cats surviving to discharge). Histopathology predominantly included meningothelial and transitional subtypes. Recurrence was detected on MRI in 3/6 cases undergoing follow-up imaging. Relevance and novel information: Surgical resection of feline meningiomas is a feasible treatment option with excellent outcomes for cats surviving the immediate postoperative period. The study demonstrates a high MST and low recurrence rate among treated cats, with surgery being curative in many cases. These results enable the veterinary general practitioner to more accurately assess the risks and benefits of surgical treatment of feline intracranial meningioma and discuss treatment with owners.


  • Open Access

    Field safety and efficacy study with a cannabidiol/cannabidiol acid-rich hemp paste in cats with osteoarthritic pain

    by Liza M Mulder, Jeanine Deterd Oude Weme, Niels R Blees, Joseph J Wakshlag, Daniel Hughes, Ronald Jan Corbee

    Objectives: Feline osteoarthritis (OA) is a common, degenerative joint condition that is an important cause of chronic pain in cats. Cannabinoids have shown potential in reducing pain and inflammation in OA, but research in cats is limited. This study aimed to assess the safety and efficacy of a cannabidiol (CBD)/cannabidiol acid (CBDA) paste would in cats with OA. We hypothesised that CBD/CBDA paste would reduce pain scores and would be safe for use without significant adverse effects. Methods: In this randomised, double-blinded, placebo-controlled crossover study, client-owned cats with OA were assigned to two study groups and received a 6-week course of both CBD/CBDA paste and a placebo. During the initial consultation and following appointments, cats underwent orthopaedic examination pain assessment with the North Carolina State University Translational Research in Pain (TRiP) Feline Musculoskeletal Pain Index scoring system and blood examination. Owners filled in a bi-weekly questionnaire (Dutch Orthopaedic Rating for Feline Osteoarthritis Pain, DORFOP). TRiP and DORFOP scores were analysed using mixed-effects models. Clinical chemistry in week 6 was compared using paired t -tests. Results: A total of 26 cats participated in the study. Of these, 12 dropped out primarily because of their refusal to eat the CBD/CBDA paste, and, in some cases, vomiting was reported. Fourteen cats were left to complete the study. CBD/CBDA paste significantly reduced TRiP and DORFOP scores after 6 weeks of administration, with changes in DORFOP starting after 2 weeks. No differences in clinical biochemistry were observed between the placebo and CBD/CBDA paste at week 6. Conclusions and relevance: CBA/CBDA paste effectively reduced pain in cats, but the high drop-out rate is concerning. Further research with larger sample sizes and longer treatment durations is needed to confirm these findings.


  • Open Access

    Collagen Hydrolysates as Nutritional Support in Canine Osteoarthritis: A Narrative Review

    by Niels R. Blees, Michelle Teunissen, Britta Dobenecker, Janne Prawitt, Marianna A. Tryfonidou, Ronald Jan Corbee

    Osteoarthritis (OA) is a common disease in dogs with severe impact on their welfare. The multimodal management of OA includes feeding therapeutic diets and nutraceuticals to slow down OA progression. Collagen hydrolysates (CH) are a nutritional supplement that may exert anabolic effects on osteoarthritic joint cartilage as well as disease‐modifying effects. After oral intake, CH is absorbed, mainly as amino acids, di‐ and tripeptides that are transported amongst others to the joint. In addition to reducing cartilage degradation, CH metabolites may reduce synovial inflammation and subchondral bone sclerosis during OA. Preliminary evidence in dogs suffering from the consequences of OA support the clinical efficacy of CH with reported reductions in lameness. However, effects on biomarker level of cartilage metabolism and inflammation are inconclusive. Additionally, current studies show a lack of standardised dosing regimens and the use of not validated outcomes. Future work should therefore elucidate further on the bioavailability of CH in dogs in order to establish adequate dosing recommendations. Furthermore, high‐quality placebo‐controlled randomised controlled trials are essential to dstudies have evaluated the cetermine the clinical efficacy of CH to reduce lameness, prevent OA progression and thereby improve the level of evidence.


  • Open Access

    Nutritional consulting in regular veterinary practices in Belgium and the Netherlands

    by Niels R. Blees, Veerle L. Vandendriessche, Ronald J. Corbee, Philippe Picavet, Myriam Hesta

    Background: Increased interest in nutrition by dog and cat owners stresses the importance of providing tailored nutritional guidance for each patient by veterinarians. The World Small Animal Veterinary Association (WSAVA) has provided guidelines to help veterinarians implement this in every‐day patient care, by screening patients for the presence of nutritional risk factors, establishing tailored nutritional plans and providing adequate patient follow‐up tools.Objectives: This study aimed to assess the use of nutritional assessments in companion animal practices, and to investigate differences between Dutch and Belgian veterinarians.Methods: A survey was conducted among Dutch and Belgian veterinarians. Of the 423 respondents, 53% were from Belgium, and 47% were from the Netherlands.Results: Only 21% had prior knowledge of the WSAVA nutritional assessment guidelines. General trends in the usage of nutritional assessments were similar in the examined countries. Aside from weighing, diet evaluation by collecting dietary information and body condition or muscle condition scoring were used infrequently, mostly due to insufficient knowledge of the methods. Nutritional recommendations were often made as part of a treatment plan, and were mostly made by veterinarians, but in Dutch practices also by veterinary nurses.Conclusion: Despite the fact that nutritional recommendations are a regular part of treatment plans, nutritional risk factors may be missed due to a lack of completely performed nutritional assessments. It remains important to promote the benefits of regular nutritional assessments to veterinarians, which will improve patients’ health.


  • Open Access

    Influence of macronutrient composition of commercial diets on circulating leptin and adiponectin concentrations in overweight dogs

    by Niels Roderick Blees, Jeannette Wolfswinkel, Hans Sjoerd Kooistra, Ronald Jan Corbee

    Leptin and adiponectin play important roles in obesity‐related inflammation and comorbidities. Previous research suggests that alterations in dietary macronutrient composition can modify circulating leptin and adiponectin concentrations in people, but limited research on this subject has been performed in dogs. This study investigated the effects of commercial high protein (HP), high fat (HF) and high carbohydrate medium protein (HCMP) diets on baseline (T−1) concentrations, post‐prandial peak concentrations and total release in a ten‐hour time span of leptin and adiponectin in dogs, when compared to a maintenance high carbohydrate low protein (HCLP) diet. Thirty‐six overweight dogs were fed the HCLP diet in a one‐week control period, after which the animals were assigned to one of three groups. In three four‐week periods, each group was fed all test diets in a different sequence. At the last day of each period, blood was sampled at one hour before feeding (T−1) and at three (T3), six (T6) and nine (T9) hours after feeding. Feeding caused peak leptin concentrations at T6 and T9 (p < .001). No significant post‐prandial change in adiponectin concentrations was found (p = .056). The HP diet resulted in lower leptin peak concentrations (p = .004) and AUCT−1–T9 (p = .01), but none of the diets influenced baseline leptin concentrations (p = .273). Baseline adiponectin concentrations were lower for the HF diet (p = .018) and HCMP (p < .001), and the HP, HF and HCMP AUCT−1–T9 (p < .001) were lower compared with the HCLP diet. Female dogs had lower adiponectin baseline concentrations (p = .041) and AUCT−1–T9 (p = .023) than male dogs. In conclusion, the HP diet was associated with the lowest post‐prandial peak leptin concentration and the least decrease in adiponectin release, suggesting that a HP diet may improve immune‐metabolic health and post‐prandial satiety in overweight dogs.